Mats Holmberg

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: FRONTIERS IN HUMAN NEUROSCIENCE. 2025;19:1559914
Assessing prefrontal cortex activity in Graves' disease: a functional near-infrared spectroscopy study
Skau S; Holmberg M; Johansson B; Kall LB; Malmgren H; Kuhn H-G; Nystrom HF
Article: ENDOCRINE PRACTICE. 2025;31(4):447-454
Rituximab Treatment as Second-Line Therapy in Glucocorticoid Nonresponsive Graves' Orbitopathy: A Nonrandomized, Controlled, Interventional Study
Manousou S; Holmberg M; Ekdahl E; Malmgren H; Nystrom HF
Article: JOURNAL OF INTERNAL MEDICINE. 2025;297(2):156-172
Longitudinal changes in regional fat and muscle composition and cardiometabolic biomarkers over 5 years of hormone therapy in transgender individuals
Lundberg TR; Tryfonos A; Eriksson LMJ; Rundqvist H; Rullman E; Holmberg M; Maqdasy S; Linge J; Leinhard OD; Arver S; Andersson DP; Wiik A; Gustafsson T
Article: NATURE. 2024;633(8028):155-164
Immune system adaptation during gender-affirming testosterone treatment
Lakshmikanth T; Consiglio C; Sardh F; Forlin R; Wang J; Tan Z; Barcenilla H; Rodriguez L; Sugrue J; Noori P; Ivanchenko M; Paez LP; Gonzalez L; Mugabo CH; Johnsson A; Ryberg H; Hallgren A; Pou C; Chen Y; Mikes J; James A; Dahlqvist P; Wahlberg J; Hagelin A; Holmberg M; Degerblad M; Isaksson M; Duffy D; Kampe O; Landegren N; Brodin P
Article: JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. 2024;47(9):2249-2260
Adipokine secretion and lipolysis following gender-affirming treatment in transgender individuals
Subramanian N; Wiik A; Rullman E; Melin M; Lundberg TR; Flanagan J; Holmberg M; Dekanski A; Dhejne C; Arver S; Gustafsson T; Laurencikiene J; Andersson DP
Article: ARCHIVES OF SEXUAL BEHAVIOR. 2024;53(5):1873-1884
Gender Incongruence and Autistic Traits: Cerebral and Behavioral Underpinnings
Khorashad BS; Wang Y; Holmberg M; Dhejne C; Savic I
Article: EUROPEAN THYROID JOURNAL. 2024;13(1):e230247
Psychiatric complications in Graves' disease
Holmberg M; Malmgren H; Berglund PF; Johansson B; Nystroem HF
Article: THYROID. 2023;33(11):1349-1357
Fracture Incidence in Graves' Disease: A Population-Based Study.
Khamisi S; Udumyan R; Sjölin G; Calissendorff J; Filipsson Nyström H; Holmberg M; Hallengren B; Lantz M; Planck T; Wallin G; Ljunggren Ö
Article: WOMEN'S HEALTH REPORTS. 2023;4(1):487-496
Long-Term Outcome of Graves' Disease: A Gender Perspective
Calissendorff J; Cramon PK; Hallengren B; Khamisi S; Lantz M; Planck T; Sjolin G; Wallin G; Holmberg M
Journal article: ENDOCRINE ABSTRACTS. 2023
Thyroid antibodies and early response to treatment in graves' disease
Tammelin K; Holmberg M; Filipsson NH
Journal article: ENDOCRINE ABSTRACTS. 2023
Rituximab treatment in patients with graves' orbitopathy who are non-responsive to intravenous glucocorticoids is not better than IV glucocorticoids alone
Manousou S; Holmberg M; Ekdahl E; Malmgren H; Skodell L; Filipsson NH
Journal article: ENDOCRINE ABSTRACTS. 2023
The relationship between mental fatigue, anxiety and depression in graves disease
Holmberg M; Berglund P; Johansson B; Malmgren H; Skau S; Filipsson NH; Jonsson A
Article: EUROPEAN THYROID JOURNAL. 2023;12(4):e230040
The relationship between mental fatigue, depression, and cognition in Graves' disease
Johansson B; Holmberg M; Skau S; Malmgren H; Filipsson Nystrom H
Article: ANDROLOGY. 2023;11(1):93-102
Testosterone replacement in prostate cancer survivors with testosterone deficiency: Study protocol of a randomized controlled trial
Valderrabano RJ; Pencina K; Storer TW; Reid KF; Kibel AS; Burnett AL; Huang G; Dorff T; Privat F; Ghattas-Puylara C; Wilson L; Latham NK; Holmberg M; Bhasin S
Article: EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY. 2022;29(15):2017-2026
Cardiovascular outcomes in transgender individuals in Sweden after initiation of gender-affirming hormone therapy
Karalexi MA; Frisell T; Cnattingius S; Holmberg D; Holmberg M; Kollia N; Skalkidou A; Papadopoulos FC
Article: THYROID RESEARCH. 2022;15(1):20
Long term outcome after toxic nodular goitre
Sjolin G; Watt T; Bystrom K; Calissendorff J; Cramon PK; Nystrom HF; Hallengren B; Holmberg M; Khamisi S; Lantz M; Planck T; Torring O; Wallin G
Article: BRITISH JOURNAL OF RADIOLOGY. 2022;95(1133):20211094
Assessment of anterior thigh muscle size and fat infiltration using single-slice CT imaging versus automated MRI analysis in adults
Niklasson E; Borga M; Leinhard OD; Widholm P; Andersson DP; Wiik A; Holmberg M; Brismar TB; Gustafsson T; Lundberg TR
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2022;107(4):1040-1052
A Longitudinal Study of Medial Temporal Lobe Volumes in Graves Disease
Holmberg M; Malmgren H; Heckemann RA; Johansson B; Klasson N; Olsson E; Skau S; Starck G; Nystrom HF
Article: EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES. 2021;129(11):783-790
β₁-adrenergic and Muscarinic Acetylcholine Type 2 Receptor Antibodies are Increased in Graves' Hyperthyroidism and Decrease During Antithyroid Therapy
Tammelin K; Lundgren A; Holmberg M; Andersson B; Nystrom HF
Article: ENDOCRINOLOGY, DIABETES & METABOLISM. 2021;4(3):e00244
Treatment of patients with Graves' disease in Sweden compared to international surveys of an 'index patient'
Sjolin G; Bystrom K; Holmberg M; Torring O; Khamisi S; Calissendorff J; Lantz M; Hallengren B; Filipsson Nystrom H; Planck T; Wallin G
Article: NEUROIMAGE-CLINICAL. 2021;29:102517
Predicting outcomes of cross-sex hormone therapy in transgender individuals with gender incongruence based on pre-therapy resting-state brain connectivity
Moody TD; Feusner JD; Reggente N; Vanhoecke J; Holmberg M; Manzouri A; Khorashad BS; Savic I
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2020;105(3):dgz247-E813
Muscle Strength, Size, and Composition Following 12 Months of Gender-affirming Treatment in Transgender Individuals
Wiik A; Lundberg TR; Rullman E; Andersson DP; Holmberg M; Mandic M; Brismar TB; Leinhard OD; Chanpen S; Flanagan JN; Arver S; Gustafsson T
Article: BMJ OPEN. 2019;9(11):e031168
Structural brain changes in hyperthyroid Graves' disease: protocol for an ongoing longitudinal, case- controlled study in Goteborg, Sweden-the CogThy project
Holmberg MO; Malmgren H; Berglund P; Bunketorp-Kall L; Heckemann RA; Johansson B; Klasson N; Olsson E; Skau S; Filipsson HN
Article: THYROID. 2019;29(11):1545-1557
The Long-Term Outcome of Treatment for Graves' Hyperthyroidism
Sjolin G; Holmberg M; Torring O; Bystroem K; Khamisi S; de Laval D; Abraham-Nordling M; Calissendorff J; Lantz M; Hallengren B; Filipsson Nystrom H; Wallin G
Article: EUROPEAN JOURNAL OF NEUROSCIENCE. 2019;50(8):3269-3281
Cross sex hormone treatment is linked with a reversal of cerebral patterns associated with gender dysphoria to the baseline of cisgender controls
Kilpatrick LA; Holmberg M; Manzouri A; Savic I
Article: THYROID. 2019;29(3):322-331
Impaired Quality of Life After Radioiodine Therapy Compared to Antithyroid Drugs or Surgical Treatment for Graves' Hyperthyroidism: A Long-Term Follow-Up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey
Torring O; Watt T; Sjolin G; Bystrom K; Abraham-Nordling M; Calissendorff J; Cramon PK; Nystrom HF; Hallengren B; Holmberg M; Khamisi S; Lantz M; Wallin G
Article: NATURE REVIEWS UROLOGY. 2019;16(2):121-139
Supporting sexuality and improving sexual function in transgender persons
Holmberg M; Arver S; Dhejne C
Article: CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS. 2018;10:148-153
Metabolic and functional changes in transgender individuals following cross-sex hormone treatment: Design and methods of the GEnder Dysphoria Treatment in Sweden (GETS) study
Wiik A; Andersson DP; Brismar TB; Chanpen S; Dhejne C; Ekstrom TJ; Flanagan JN; Holmberg M; Kere J; Lilja M; Lindholm ME; Lundberg TR; Maret E; Melin M; Olsson SM; Rullman E; Wahlen K; Arver S; Gustafsson T
Visa fler

Alla övriga publikationer

Corrigendum: NATURE. 2024;634(8033):E5
Immune system adaptation during gender-affirming testosterone treatment (vol 633, pg 155, 2024)
Lakshmikanth T; Consiglio C; Sardh F; Forlin R; Wang J; Tan Z; Barcenilla H; Rodriguez L; Sugrue J; Noori P; Ivanchenko M; Paez LP; Gonzalez L; Mugabo CH; Johnsson A; Ryberg H; Hallgren A; Pou C; Chen Y; Mikes J; James A; Dahlqvist P; Wahlberg J; Hagelin A; Holmberg M; Degerblad M; Isaksson M; Duffy D; Kampe O; Landegren N; Brodin P
Letter: JAMA PEDIATRICS. 2023;177(7):726-727
Incidence of Idiopathic Intracranial Hypertension in Individuals With Gonadotropin-Releasing Hormone Analogue Treatment for Gender Dysphoria in Sweden
Karamanis G; Frisell T; Holmberg M; Halldin M; Sylven S; Skalkidou A; Papadopoulos FC
Other: JOURNAL OF SEX & MARITAL THERAPY. 2023;49(2):243-245
Before We Were Trans. A New History of Gender
Holmberg M
Preprint: MEDRXIV. 2020
Predicting outcomes of cross-sex hormone therapy in gender dysphoria based on pre-therapy resting-state brain connectivity
Moody TD; Feusner JD; Reggente N; Vanhoecke J; Holmberg M; Manzouri A; Khorashad BS; Savic I
Preprint: BIORXIV. 2019
Muscle strength, size and composition following 12 months of gender-affirming treatment in transgender individuals: retained advantage for the transwomen
Wiik A; Lundberg TR; Rullman E; Andersson DP; Holmberg M; Mandić M; Brismar TB; Dahlqvist Leinhard O; Chanpen S; Flanagan J; Arver S; Gustafsson T
Other: BASIC AND CLINICAL ANDROLOGY. 2018;28:13
Male reproductive health statement (XIIIth international symposium on Spermatology, may 9th-12th 2018, Stockholm, Sweden
Levine H; Mohri H; Ekbom A; Ramos L; Parker G; Roldan E; Jovine L; Koelle S; Lindstrand A; Immler S; Mortimer S; Mortimer D; van der Horst G; Ishijima S; Aneck-Hahn N; Baldi E; Menkveld R; Rothmann SA; Giwercman A; Giwercman Y; Holmberg M; Kvist U; Bjorndahl L; Holmberg R; Arver S; Flanagan J; Drevet JR

Anställningar

Adjungerad Adjunkt, Medicin, Huddinge, Karolinska Institutet, 2023-2027
Anknuten till Forskning, Medicin, Huddinge, Karolinska Institutet, 2022-2025

Artiklar

Alla övriga publikationer

Anställningar

Nyheter från KI

Kalenderhändelser från KI